Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKesson
Baxter
McKinsey
Harvard Business School

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

EXTAVIA Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Tradename: EXTAVIA
Patents:37
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for EXTAVIA
Recent Clinical Trials for EXTAVIA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
BiogenPhase 4
Charite University, Berlin, GermanyPhase 2/Phase 3
NeuroCure Clinical Research CenterPhase 2/Phase 3

See all EXTAVIA clinical trials

Patent Text Search: US Patents for EXTAVIA

These patents were identified by searching patent claims

Supplementary Protection Certificates for EXTAVIA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1690055-7 Sweden   Start Trial PRODUCT NAME: DACLIZUMAB OR A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE THEREOF; REG. NO/DATE: EU/1/16/1107 20160705
16C1017 France   Start Trial PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
93315 Luxembourg   Start Trial PRODUCT NAME: PROCEDE DE TRAITEMENT DE LA SCLEROSE MULTIPLE - DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107
313 5027-2016 Slovakia   Start Trial PRODUCT NAME: DAKLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
C20160039 00209 Estonia   Start Trial PRODUCT NAME: DAKLIZUMAB;REG NO/DATE: EU/1/16/1107 05.07.2016
CA 2016 00058 Denmark   Start Trial PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Baxter
Express Scripts
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.